Article

The time is right: proteome biology of stem cells.

Stem Cell and Leukemia Proteomics Laboratory, Faculty of Medical and Human Sciences, University of Manchester, Christie Hospital, Manchester M20 9BX, UK.
Cell stem cell (Impact Factor: 23.56). 04/2008; 2(3):215-7. DOI: 10.1016/j.stem.2008.02.003
Source: PubMed

ABSTRACT In stem cell biology, there is a growing need for advanced technologies that may help to unravel the molecular mechanisms of self-renewal and differentiation. Proteomics, the comprehensive analysis of proteins, is such an emerging technique. To facilitate interactions between specialists in proteomics and stem cell biology,a new initiative has been undertaken, supported by the Human Proteome Organization (HUPO) and the International Society for Stem Cell Research (ISSCR). Here we present the Proteome Biology of Stem Cells Initiative (PBSCI) and report on its goals and future activities.

0 Bookmarks
 · 
125 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Pluripotency of embryonic stem cells (ESCs)/induced pluripotent stem cells (iPSCs) and reprograming of somatic cells (SCs) to pluripotency are governed by known and unknown factors. These factors, including protein complexes, are poorly described at the proteome level. Here, we established the quantitative proteomic profiles across three types of cells (iPSCs, ESCs, and SCs) using OFFGEL fractionation coupled with LTQ-Orbitrp analysis. Additionally, we utilized the previously published proteomic profiles of iPSCs, ESCs, and SCs. By integrating these proteomic profiles with protein-protein interaction resources, we identified numerous protein complexes in iPSCs and/or ESCs, which include known and novel chromatin remodeling complexes that facilitate cell reprograming. The identified protein complexes also include the previously unreported ones that are associated with the imperfect aspects of iPSCs or cell reprograming process. Further, we performed a comparison between our study and previously published studies and highlighted a partial conservation of the identified protein complexes across the iPSCs generated by different laboratories and iPS cell-type specific protein complexes. The identified protein complexes were validated by integrated in silico analysis of microarray repository data related to ESCs differentiation into embryoid bodies. A majority of the protein complexes exhibited significant (p < 0.005) co-regulation of their components upon ESC differentiation, suggesting their role in the maintenance of the pluripotent state. Finally, we showed a link between the components of the protein complexes and embryonic development using the existing loss-of-function phenotype data. Together, our integrated approach provides the first comprehensive view of the protein complexes that may have implications for cell reprograming and pluripotency.
    Journal of Proteome Research 11/2013; · 5.06 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The generation of human induced pluripotent stem cells (iPSCs) from differentiated cells holds important clinical implications. Human iPSCs represent the most promising resource for regenerative medicine by enabling the use of patient-specific cells of any lineage without the need for embryonic material. However, before therapeutic applications using human iPSCs are carried out, extensive analyses are needed to assess molecular differences and similarities between human iPSCs and their natural counterparts, human embryonic stem cells. The pluralism of mechanisms acting in a biological system can be better approached by studying several elements simultaneously in an unbiased manner. This review will discuss recent genome-wide analyses of iPSCs (e.g., transcripts and epigenetics) and will introduce the huge potential of mass spectrometry-based proteomics in decoding the unique mechanisms underlying the reprogramming process and the molecular nature of cellular identity.
    Expert Review of Proteomics 08/2012; 9(4):379-99. · 3.90 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The efficacy of glioma therapy can be considerably improved if it eliminates cancer stem cells (CSCs); however, to achieve this, CSCs markers are required. This study investigated the influence of micro-environmental changes on CSCs in hypoxic, serum deprived U87-MG and the corresponding control cells. Proteomic analysis produced a wide dataset, depicting the changes that occur at the proteomic level in the differentiated and undifferentiated U87-MG cell line. With the IPA analysis, HPRD and literature reviews, 11 proteins were proposed as potential differentiated biomarkers for CSCs namely Hsp90β1, vimentin, PGK1, GAPDH, EIF4e, TPI1, HspA8, HNRNPK, NAMPT, CCSNK2A1, and ANXA2.
    Cancer Investigation 06/2013; · 2.24 Impact Factor

Full-text (2 Sources)

Download
38 Downloads
Available from
May 20, 2014